Akebia Therapeutics, Inc. (AKBA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | N/A |
| Enterprise value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.33 |
| 52-week change 3 | N/A |
| S&P500 52-week change 3 | N/A |
| 52-week high 3 | 4.3300 |
| 52-week low 3 | 0.3000 |
| 50-day moving average 3 | 0.7810 |
| 200-day moving average 3 | 2.1000 |
Share statistics
| Avg vol (3-month) 3 | 11.39M |
| Avg vol (10-day) 3 | 8.89M |
| Shares outstanding 5 | 174.96M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 179.2M |
| % held by insiders 1 | 1.16% |
| % held by institutions 1 | 53.92% |
| Shares short (28 Apr 2022) 4 | 19.12M |
| Short ratio (28 Apr 2022) 4 | 1.06 |
| Short % of float (28 Apr 2022) 4 | 10.53% |
| Short % of shares outstanding (28 Apr 2022) 4 | 10.42% |
| Shares short (prior month 30 Mar 2022) 4 | 21.41M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Dec 2021 |
Profitability
| Profit margin | -132.43% |
| Operating margin (ttm) | -106.81% |
Management effectiveness
| Return on assets (ttm) | -24.38% |
| Return on equity (ttm) | -174.55% |
Income statement
| Revenue (ttm) | 213.58M |
| Revenue per share (ttm) | 1.29 |
| Quarterly revenue growth (yoy) | 5.10% |
| Gross profit (ttm) | -17.92M |
| EBITDA | -190.16M |
| Net income avi to common (ttm) | -282.84M |
| Diluted EPS (ttm) | -1.8870 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 149.8M |
| Total cash per share (mrq) | 0.83 |
| Total debt (mrq) | 136.05M |
| Total debt/equity (mrq) | 177.94 |
| Current ratio (mrq) | 1.06 |
| Book value per share (mrq) | 0.79 |
Cash flow statement
| Operating cash flow (ttm) | -252.96M |
| Levered free cash flow (ttm) | -141.62M |
© 2022 Yahoo. All rights reserved.
